New understanding of lung cancer cells’ ‘memories’ suggests novel treatment approach

A new understanding of lung cancer cells’ “memories” suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found.

HLTH 2024 buzz: GLP-1s, AI copilots, and a mysterious robot

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

October 22, 2024

Immunome buys desmoid tumor asset; UK looks into Thermo Fisher-Olink deal; Kyverna’s upsized IPO

Plus, news about Attralus, Sangamo, Mithra, NeOnc, 4D Molecular Therapeutics and Immix Biopharma: Immunome buys Ayala’s desmoid tumor asset: The biotech will pay $20 million

February 7, 2024

Gottlieb says RFK Jr. as HHS secretary could bring ‘tragic’ outbreaks

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.